A detailed history of Capital Market Strategies LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Market Strategies LLC holds 10,590 shares of ABBV stock, worth $1.83 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
10,590
Previous 10,681 0.85%
Holding current value
$1.83 Million
Previous $1.83 Million 14.14%
% of portfolio
1.31%
Previous 1.2%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$163.84 - $199.33 $14,909 - $18,139
-91 Reduced 0.85%
10,590 $2.09 Million
Q2 2024

Jul 01, 2024

BUY
$154.79 - $180.76 $47,210 - $55,131
305 Added 2.94%
10,681 $1.83 Million
Q1 2024

Apr 05, 2024

SELL
$159.82 - $182.1 $84,384 - $96,148
-528 Reduced 4.84%
10,376 $1.89 Million
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $94,806 - $106,774
-689 Reduced 5.94%
10,904 $1.69 Million
Q3 2023

Oct 18, 2023

SELL
$133.59 - $154.65 $40,477 - $46,858
-303 Reduced 2.55%
11,593 $1.73 Million
Q2 2023

Jul 06, 2023

SELL
$132.51 - $164.9 $17,358 - $21,601
-131 Reduced 1.09%
11,896 $1.6 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $83,150 - $95,760
575 Added 5.02%
12,027 $1.92 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $4,010 - $4,810
-29 Reduced 0.25%
11,452 $0
Q3 2022

Oct 14, 2022

BUY
$134.21 - $153.93 $8,186 - $9,389
61 Added 0.53%
11,481 $1.54 Million
Q2 2022

Jul 11, 2022

BUY
$137.62 - $174.96 $73,213 - $93,078
532 Added 4.89%
11,420 $1.75 Million
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $35,370 - $43,885
-268 Reduced 2.4%
10,888 $1.77 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $1.2 Million - $1.52 Million
11,156 New
11,156 $1.51 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Market Strategies LLC Portfolio

Follow Capital Market Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Market Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Market Strategies LLC with notifications on news.